“The global push to develop an AIDS vaccine was boosted by the first alliance between a major drug-maker and the non-profit sector to tackle the disease.

“Pharmaceuticals giant GlaxoSmithKline has signed a deal with the International AIDS Vaccine Initiative (IAVI) to research and develop a vaccine.

“Development will concentrate on a chimpanzee virus which has been engineered so that it is non-infectious but can spark the immune system of humans into responding against HIV, the virus that causes AIDS.”

Read more at Glaxo To Help Develop AIDS Vaccine

Recent Entries

• Sigma Pharmaceuticals year profit rises 27 pct
• South African citizens cheap drug guinea pigs
• Two drugs test victims face a year in coma
• Can drug companies improve their reputation?
• Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
• Pfizer’s Forecast Disappoints
• Pharmaceutical RFID Adoption Stalls
• Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
• GlaxoSmithKline unveils best results since merger
• Pfizer Sues Teva, Sandoz Over Zithromax

This entry was posted on Thursday, June 23rd, 2005 at 3:23 am and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.